Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: Systematic review and meta-analysis

Psychosomatic Medicine

Volumn 76, Issue 5, 2014, Pages 389-398

  Schaefert, Rainer ^a   Klose, Petra ^b   Moser, Gabriele ^c   Häuser, Winfried ^d,e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d KLINIKUM SAARBRÜCKEN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

hypnosis; irritable bowel syndrome; meta analysis; systematic review

Indexed keywords

ARTICLE; DATA BASE; FOLLOW UP; HUMAN; HYPNOSIS; IRRITABLE COLON; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; IRRITABLE BOWEL SYNDROME; METHODOLOGY; PANIC DISORDER; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; STATISTICAL BIAS; TREATMENT OUTCOME;

ADULT; BIAS (EPIDEMIOLOGY); FOLLOW-UP STUDIES; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; PANIC DISORDER; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84903312757     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000039     Document Type: Article

References (35)

1. LovellRM, Ford AC.Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-21.
2. Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 2011;45(suppl):S98-101.
3. Corney RH, Stanton R. Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res 1990;34:483-91.
4. Drossman DA, Chang L, Bellamy N, Gallo-Torres HE, Lembo A, Mearin F, Norton NJ, Whorwell P. Severity in irritable bowel syndrome: A Rome Foundation Working Team report. Am J Gastroenterol 2011;106:1749-59.
5. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N,Whorwell P; Clinical Services Committee of The British Society of Gastroenterology. Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut 2007;56:1770-98.
6. Dalrymple J,Bullock I. Diagnosis and management of irritable bowel syndrome in adults in primary care: Summary of NICE guidance. BMJ 2008;336:556-8.
7. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(suppl 1):S1-35.
8. Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P. Irritable bowel syndrome Vthemain recommendations.Dtsch Arztebl Int 2011;108:751-60.
9. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis. Gut 2009;58:367-78.
10. Hefner J, Rilk A, Herbert BM, Zipfel S, Enck P, Martens U. Hypnotherapy for irritable bowel syndromeVa systematic review. Z Gastroenterol 2009; 47:1153-9.
11. Webb AN, Kukuruzovic RH, Catto-Smith AG, Sawyer SM. Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2007:CD005110.
12. Wilson S, Maddison T, Roberts L, Greenfield S, Singh S; Birmingham IBS Research Group. Systematic review: The effectiveness of hypnotherapy in the management of irritable bowel syndrome. Aliment Pharmacol Ther 2006;24:769-80.
13. Rutten JM, Reitsma JB, Vlieger AM, Benninga MA. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: A systematic review. Arch Dis Child 2013;98:252-7.
14. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews Of Intervention. Version 5.01. Available at: www.cochrane.org/resources/handbook/ handbook.pdf
15. Spiegel B, Camilleri M, Bolus R, Andresen V, CheyWD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: A Rome Foundation report. Gastroenterology 2009;137(6):1944-53.
16. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
18. Yates SL, Morley S, Eccleston E,Williams A. A scale for rating the quality of psychological trials for pain. Pain 2005;117:314-25.
19. Bernardy K, Füber N, Köllner V, HäuserW. Efficacy of cognitive-behavioral therapies in fibromyalgia syndromeVa systematic review and metaanalysis of randomized controlled trials. J Rheumatol 2010;37:1991-2005.
20. Laird NM, Mostellier F. Some statistical methods for combining experimental results. In J Technol Assess Health Care 1990;6:5-30.
21. ReviewManager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
22. Simrén M, Ringström G, Björnsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004;66:233-8.
23. Palsson OS, Turner MJ, Johnson DA, Burnett CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: Investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47:2605-14.
24. Galovski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998;23:219-32.
25. Roberts L, Wilson S, Singh S, Roalfe A, Greenfield S. Gut directed hypnotherapy for irritable bowel syndrome: Piloting a primary care based randomised controlled trial. Br J Gen Pract 2006;56:115-21.
26. Whorwell PJ, Prior A, FaragherEB.Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4.
27. Lindfors P, Unge P, Arvidsson P, Nyhlin H, Björnsson E, Abrahamsson H, Simrén M. Effects of gut-directed hypnotherapy on IBS in different clinical settingsVresults from two randomized, controlled trials. Am J Gastroenterol 2012;107:276-85.
28. Moser G, Trägner S, Gajowniczek EE, Mikulits A, Michalski M, Kazemi-Shirazi L, Kulnigg-Dabsch S, Führer M, Ponocny-Seliger E, Dejaco C, Miehsler W. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: A randomized controlled trial. Am J Gastroenterol 2013;108:602-9.
29. Lowén MB, Mayer EA, Sjöberg M, Tillisch K, Naliboff B, Labus J, Lundberg P, Ström M, Engström M, Walter SA. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 2013;37: 1184-97.
30. Gonsalkorale WM. Gut-directed hypnotherapy: The Manchester approach for treatment of irritable bowel syndrome. Int J Clin Exp Hypn 2006; 54:27-50.
31. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-9.
32. Lindfors P, Unge P, Nyhlin H, Ljótsson B, Björnsson ES, Abrahamsson H, Simrén M. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol 2012;47:414-20.
33. Dobbin A, Dobbin J, Ross SC, Graham C, Ford MJ. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome. J R Coll Physicians Edinb 2013;43:15-23.
34. Gonsalkorale W, Toner B, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004;56:271-8.
35. Carruthers HR, Morris J, Tarrier N, Whorwell PJ. Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome. BMC Complement Altern Med 2010;10:75.